EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long-Term Follow-Up of Levetiracetam Monotherapy Versus Add-On Therapy in Pediatric Epilepsy

Yukiko Osada, Kosuke Nakano, Masayoshi Nakakuni, Jun Tsuchiya, Madoka Watanabe, Shinji Kobayashi, Miki Akabane, Yoshiaki Yamamoto, Akimasa Yamatani iD

Children · 28.07.2026 · 13 (8) · 997

DOI: 10.3390/children13080997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Children, online erschienen am 28.07.2026. Verfasst von Yukiko Osada und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Meiji Pharmaceutical University, Tokyo 204-8588, Japan. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Epilepsy treatment often continues long-term from childhood. However, evidence comparing long-term treatment persistence and adverse events (AEs) between levetiracetam (LEV) monotherapy and LEV-containing combination therapy in pediatric patients is limited. This study compared the retention rate and the rate of AEs, including irritability and insomnia, between these treatment strategies. Methods: A retrospective cohort study was conducted using data from the Pediatric Medical Information Collection System database. Patients aged ≥0 to

Schlagwörter

Stichwörter der Autor:innen

add-on therapydatabase studyepilepsyinsomniairritabilitylevetiracetammonotherapypediatricretention rate

Autor:innen und Institutionen

  • Graduate School of Pharmaceutical Sciences, Meiji Pharmaceutical University, Tokyo 204-8588, Japan.
  • Department of Pharmacy, National Center for Child Health and Development, Tokyo 157-8535, Japan.
  • MSD K.K., Tokyo 102-8667, Japan.
  • Clinical Research Center, National Center for Child Health and Development, Tokyo 157-8535, Japan.
  • H&H CONNECT Co., Ltd., Tokyo 104-0033, Japan.
  • Nature Insight Co., Ltd., Tokyo 101-0021, Japan.

ORCID-Profile: Akimasa Yamatani

Zitieren

APA

Osada, Y., Nakano, K., Nakakuni, M., Tsuchiya, J., Watanabe, M., Kobayashi, S., Akabane, M., Yamamoto, Y., & Yamatani, A. (2026). Long-Term Follow-Up of Levetiracetam Monotherapy Versus Add-On Therapy in Pediatric Epilepsy. Children, 13(8), 997. https://doi.org/10.3390/children13080997

Vancouver

Osada Y, Nakano K, Nakakuni M, Tsuchiya J, Watanabe M, Kobayashi S, et al. Long-Term Follow-Up of Levetiracetam Monotherapy Versus Add-On Therapy in Pediatric Epilepsy. Children. 2026;13(8):997. doi:10.3390/children13080997

BibTeX
@article{Osada2026,
  author = {Osada, Yukiko and Nakano, Kosuke and Nakakuni, Masayoshi and Tsuchiya, Jun and Watanabe, Madoka and Kobayashi, Shinji and Akabane, Miki and Yamamoto, Yoshiaki and Yamatani, Akimasa},
  title = {Long-Term Follow-Up of Levetiracetam Monotherapy Versus Add-On Therapy in Pediatric Epilepsy},
  journal = {Children},
  year = {2026},
  volume = {13},
  number = {8},
  pages = {997},
  doi = {10.3390/children13080997}
}
Kostenlos starten →